Technical Analysis for RDUS - Radius Health, Inc.

Grade Last Price % Change Price Change
D 6.48 1.57% 0.10
RDUS closed up 1.57 percent on Thursday, January 20, 2022, on approximately normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical RDUS trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Doji - Bearish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 1.57%
Bullish Engulfing Bullish 1.57%
Lower Bollinger Band Walk Weakness 1.57%
Lower Bollinger Band Touch Weakness 1.57%
New 52 Week Closing Low Bearish 6.06%
Lower Bollinger Band Walk Weakness 6.06%
Older End-of-Day Signals for RDUS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 20 DMA about 16 hours ago
60 Minute Opening Range Breakout about 16 hours ago
Up 5% about 16 hours ago
Rose Above Previous Day's High about 17 hours ago
20 DMA Resistance about 17 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Radius Health, Inc. Description

Radius Health, Inc., a biopharmaceutical company, focuses on developing novel therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases in the United States. Its lead product includes abaloparatide (BA058), a novel synthetic peptide analog of parathyroid hormone-related protein, which is in Phase III clinical development for the treatment of osteoporosis. The company is also developing RAD1901, a selective estrogen receptor down-regulator/degrader for the treatment of breast cancer brain metastases, and vasomotor symptoms; and RAD140, a nonsteroidal selective androgen receptor modulator, which is in preclinical development stage for the treatment of weight loss due to cancer cachexia, muscle frailty and osteoporosis, and breast cancer. It has collaborations and license agreements with Nordic Bioscience Clinical Development VII A/S; 3M; Ipsen Pharma SAS; Eisai; Lonza Group Ltd.; and Charles River Laboratories, Inc. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biopharmaceutical Cancer Drugs Clinical Development Breast Cancer Treatment Of Breast Cancer Thyroid Endocrine System Hormones Amines Osteoporosis Estrogen Metastases Weight Loss Cachexia Antiestrogens Estrogen Receptor Parathyroid Hormone Androgen Receptor Brain Metastases C Peptide Eisai Selective Estrogen Receptor Modulators Treatment Of Osteoporosis

Is RDUS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 26.1599
52 Week Low 5.92
Average Volume 1,316,366
200-Day Moving Average 15.59
50-Day Moving Average 10.95
20-Day Moving Average 6.66
10-Day Moving Average 6.48
Average True Range 0.56
ADX 48.14
+DI 18.07
-DI 32.60
Chandelier Exit (Long, 3 ATRs) 5.59
Chandelier Exit (Short, 3 ATRs) 7.61
Upper Bollinger Bands 7.22
Lower Bollinger Band 6.09
Percent B (%b) 0.34
BandWidth 17.01
MACD Line -1.09
MACD Signal Line -1.40
MACD Histogram 0.3078
Fundamentals Value
Market Cap 301.63 Million
Num Shares 46.5 Million
EPS -3.70
Price-to-Earnings (P/E) Ratio -1.75
Price-to-Sales 3.23
Price-to-Book 0.00
PEG Ratio -0.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.16
Resistance 3 (R3) 7.21 7.05 7.04
Resistance 2 (R2) 7.05 6.87 7.02 7.00
Resistance 1 (R1) 6.76 6.77 6.91 6.71 6.97
Pivot Point 6.60 6.60 6.67 6.57 6.60
Support 1 (S1) 6.31 6.42 6.46 6.26 5.99
Support 2 (S2) 6.15 6.32 6.12 5.96
Support 3 (S3) 5.86 6.15 5.92
Support 4 (S4) 5.81